Journal of the National Comprehensive Cancer Network

Title Publication Date Language Citations
HSR23-113: Patient and Provider Perspectives on How COVID-19 Impacted Melanoma Care Delivery2023/03/31
CLO23-060: Extranodal Presentation of Double Hit High Grade B Cell Lymphoma2023/03/31
CLO23-027: Do Proton Pump Inhibitors Affect the Effectiveness of Capecitabine-Based Chemotherapy in Colorectal Cancers? A Systematic Review With Meta-Analysis2023/03/31
CLO23-056: Risk of Second Malignancy Among Non-Metastatic Seminoma Patients Treated With Radiation Therapy and Chemotherapy in Manitoba2023/03/31
CLO23-062: Pediatric Metastatic Pulmonary Adenocarcinoma2023/03/31
CLO23-048: Disparities in Outcomes of Chemotherapy-Related Febrile Neutropenia Patients: A Nationwide Study of Hospitalizations2023/03/31
CLO23-055: Does Anemia Contribute to Increased Risk of Adverse Outcomes in Cancer Patients With Venous Thromboembolism? A Longitudinal Study From National Representative Population2023/03/31
QIM23-133: Aligning NCCN Criteria With Testing Workflows Using a Novel Database Application (Criterion™)2023/03/31
BPI23-012: Real-World Frequency of ECHO Monitoring and Incidence of Anti-HER2 Therapy Related Cardiac Events in HER2+ Breast Cancer Patients2023/03/31
HSR23-099: Reasons for Lung Cancer Patients to Present to the ED2023/03/31
NCCN News2023/02/01
Understanding Disparities: A Case Illustrative of the Struggles Facing Transgender and Gender Diverse Patients With Cancer2023/02/01
HSR23-104: How Pancreatic Patients Choose Their Cancer Center: An Analysis of Factors That Influence Retention2023/03/31
HSR23-119: Real-World Duration of Venetoclax Treatment for Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia (CLL/SLL)2023/03/31
QIM23-139: Creating a Fellowship Curriculum: Clinical Trial Patient Conversations2023/03/31
CLO23-046: Pooled Outcomes of Anti-BRAF Agents in Advanced Stage Colorectal Cancer2023/03/31
CLO23-042: Clinical Outcomes of Radical Radiotherapy With or Without Chemotherapy in Inoperable Locally Advanced Squamous Cell Carcinoma of Oral Cavity2023/03/31
CLO23-026: Hydrogel Slope and Optimization of Prostate-Rectal Hydrogel Placement2023/03/31
YIA23-001: Targeting NKG2D Ligands Is Therapeutically Effective in NSCLC2023/03/31
HSR23-109: Real-World Combination Use of Mogamulizumab With Other Therapies Among Patients With Mycosis Fungoides and Sézary Syndrome2023/03/31
EPR23-084: Bimodal Distribution of Osteosarcoma: A Thing of the Past? Comparative Analysis From Surveillance, Epidemiology, and End Results (SEER) and National Inpatient Sample (NIS)2023/03/31
CLO23-050: Total Neoadjuvant Chemotherapy Followed by HIPEC and Curative Surgery in Treatment of Locally Advanced Gastric Cancer2023/03/31
BPI23-010: The Benefits of a Clinically Based Individualized Exercise Oncology Program on Health Care Utilization in Patients With Malignancies2023/03/31
BIO23-017: Patient Satisfaction With Electronic Health Records: Results From a Survey of Morrocan Patients in Mohammed VI Oncology Center2023/03/31
YIA23-003: CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response2023/03/31
QIM23-141: An APP Initiated Telehealth Visit to Reduce Oncology Patient Readmissions: Lessons Learned2023/03/31
CLO23-051: Real-World Use of Neratinib in Patients With HER2-Positive Early-Stage Breast Cancer Following Prior Ado-Trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade With Pertuzumab Plus Trastuzumab2023/03/31
HSR23-105: Real-World Dosing Patterns in Patients With Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Treated With Brigatinib in the Front-Line (FL) Setting in the United States: A Claims Database Analysis2023/03/31
CGE23-071: Real World Data on the Implementation of a Hereditary Hematological Myeloid Malignancy Workflow: Experience of a Single Academic Medical Center2023/03/31
HSR23-122: Disparities in Prostate Cancer Survival Outcomes in Appalachian Kentucky2023/03/31